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Abstract.  To examine the role of keratin intermediate 
filament proteins in cell structure and function, trans- 
genie mice were isolated that express a modified form 
of the human K14 keratin protein in liver hepatoeytes. 
A  modified K14 eDNA (K14.P) sequence was linked 
downstream of the mouse transthyretin  (TTR) gene 
promoter and enhancer elements to achieve targeted 
expression in hepatocytes. Hepatoeytes expressing 
high levels of the transgene were found to have abnor- 
mal keratin filament networks as detected by indirect 
immunofluorescenoe using an antibody specific for the 
transgene product.  Light and electron microscopic 
level histological analysis of isolated liver tissue 
showed in many eases degenerative changes that in- 
cluded inflammatory infiltration,  ballooning degenera- 
tion, an increase in fat containing  vacuoles, and glyco- 
gen accumulation.  These changes were most evident in 
older mice over four months of age. No indication of 
typical Mallory body structures were identified at ei- 
ther the light or electron microscopic level. To evalu- 
ate secretory function in transgenic livers, bile acid 
secretion rates were measured in isolated perfused 
liver and found to be approximately twofold lower 
than aged-matched controls.  These findings indicate 
that expression of an abnormal keratin in liver epithe- 
lial cells in the in vivo setting can alter the structure 
and function of a tissue and suggest a role of the kera- 
tin network in cellular secretion. 
I 
STER~EDIATE filament flFy proteins  comprise a multi- 
gene family of five major types that are expressed in a 
tissue-specific  manner  (for  review  see  Albers  and 
Fuchs, 1992; Fuchs and Weber,  1994). Keratin proteins are 
the largest and most complex IF group and are expressed as 
specific  pairs  during  epithelial  cell  development  and 
differentiation (Franke et al., 1982; Fuehs et al., 1987). Ker- 
atin  polypeptides assemble into  10-14-nm  diam filaments 
that form an extensive  cytoplasmic network with associa- 
tions at the nuclear and cytoplasmic membranes. 
Keratins are classified as type I or type II proteins based 
upon their charge, immunological  relatedness,  and sequence 
similarity (Fuchs et al., 1981; Moll et al., 1982). Type I ker- 
atins (K9-K20) are generally smaller in molecular mass and 
more acidic (molecular mass 40-56.5  kD; pKi 4-6) than 
type II keratins  (K1-K8), which are larger and neutral basic 
(molecular mass 53-67 kD; pK~ 6-8).  Type I and type II 
subunits  are expressed as pairs that copolymerize into het- 
eropolymer structures (Sun et al., 1984). Pairing specificity 
is thought  to create networks tailored to the function  and 
phenotypic features of an epithelium  (Eichner et al., 1986). 
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For example,  basal keratinocytes  of the stratifying  epithelia 
of the epidermis express the type I KI4 and type II K5 pro- 
teins.  These keratins  assemble into high  affinity  filament 
complexes (Coulombe and Fuchs, 1990; Quinlan et al., 1985) 
that form stable, resilient  networks that impart  strength  to 
the epidermis and facilitate its role as a protective organ. In 
contrast,  simple epithelial  cells contain keratin  filaments 
composed of keratins K18 (type I) and K8 (type 1I) that differ 
from skin keratins by having greater flexibility and solubility 
(Chou et al.,  1993). These physical properties are thought 
to be more adaptive to simple epithelium,  i.e., keratin  fila- 
ments may serve less of a protective role and more as cyto- 
plasmic organizers. 
Numerous studies and experimental approaches have been 
used  to  understand  the  role  of  keratin  protein  pairing 
specificity  and  function.  In  vitro  assembly  studies  have 
demonstrated that many combinations  of type I and type H 
subunits  polymerize to form morphologically similar  fila- 
ments (Hatzfeld and Franke,  1985).  Studies using cultured 
ceils  transfected  with  various  cloned  keratin  genes  have 
shown that expression  of ectopie keratins in epithelial  cells 
does not overtly perturb cell morphology and survival (A1- 
bers and Fuchs, 1987, 1989; Domenjoud et al., 1988; Kulesh 
and Oshima,  1988;  Lersch et al.,  1989;  Blessing  et al., 
1989), suggesting that alteration of network composition was 
not detrimental.  However, studies using retroviral promoter 
driven expression of various type I and type II keratin pairs 
in 3T3 fibroblasts,  cells that normally contain vimentin net- 
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tended filaments than others (Lu and Lane, 1990). For exam- 
ple,  K8  and  K18  proteins  assembled  into  an  extended 
filament network whereas 1(8 and KI4 proteins formed an ir- 
regular,  fragmented network. 
To examine the requirements of keratin filament composi- 
tion in tissue function, we have isolated lines of transgenic 
mice that express a modified epidermal K14 keratin in the 
simple epithelial hepatocytes of the liver. A derivative of the 
human K14 epidermal  keratin  cDNA,  K14.P  (Albers  and 
Fuchs, 1987) was expressed in liver using promoter and en- 
hancer sequences from the gene encoding the liver expressed 
serum protein, transthyretin (TTR) (Costa et al., 1990). We 
targeted K14.P expression to liver because it is a large organ 
that is well characterized structurally and biochemically and 
because in several disorders of liver, the hepatocyte IF net- 
work becomes disorganized into aggregate structures known 
as Mallory bodies.  Mallory bodies are frequently found in 
a perinuclear array, contain cross-linked keratin proteins not 
normally expressed in liver (Denk et al.,  1986; Zatloukal et 
al.,  1992), and are typically found in liver diseases in which 
hepatocyte injury is a characteristic  feature, e.g.,  alcoholic 
fiver disease, W'flson's disease, chronic biliary diseases, and 
hepatocellular carcinoma (Denk et al.,  1986; Cotran et al., 
1989).  The diversity of hepatic disorders exhibiting keratin 
abnormalities suggest that the integrity and composition of 
the keratin network has an intrinsic role in hepatocyte struc- 
ture and function.  To test this hypothesis we examined the 
histology and function of liver tissue from TTR-K14.P ex- 
pressing transgenic mice. Results show that expression of the 
K14.P protein in liver could perturb the endogenous keratin 
filament  network organization  and produce various histo- 
pathologic damage. To determine whether these morpholog- 
ical  abnormalities  affected  liver  function,  bile  secretory 
function of TTR-K14.P transgenics was assayed. Transgenic 
mice  from two separate  lines  had reduced bile  flow rates 
compared to  controls,  suggesting  that perturbation  of the 
keratin  intermediate  filament network disrupts the normal 
secretory process in hepatocytes. 
Materials and Methods 
Construction and Purification of the 
TTR-KI4.P Transgene 
A HindIH fragment containing the K14.P  coding and 3' untranslated se- 
quences was cloned into the HindIlI site of the plasmid pTTR-EP  (a gift 
from R. Costa, University of  Illinois, Chicago). Plasmid pTTR-EP contains 
the promoter and enhancer regions of the mouse transthyretin gene cloned 
into the plasmid pGem3Z (Promega,  Madison, WI). To enhance expression 
of the K14.P cDNA transgene, ,~2 kbp of the human growth hormone gene 
containing intron, exon, and a polyadenylation  signal sequences (Palmiter 
et al., 1991), were ligated at the 3' end of the KI4.P cDNA to generate plas- 
mid pG3TT-K14.P  (Fig.  1). The EcoRI TTR-K14.PhGH containing frag- 
ment was purified and used for generation of transgenic mice. Before injec- 
tion the EcoRI fragment was electrophoresed through an 0.8% Sea plaque 
gel  (FMC  Bioproducts,  Rockland,  ME),  extracted from the gel  using 
Geneclean (Bit 101), phenol/chloroform  extracted, ethanol precipitated and 
run through a NACS column (Bcthesda Research Laboratories, Galthers- 
burg, MD). DNA was ethanol precipitated and resuspended in PBS at a con- 
centration of 5 ~tg/ml as determined using a fluorometer (Fharmacia LKB 
Bioteclmology, Piscataway, NJ). Purified DNA was microinjected into sin- 
gle cell mouse embryos derived from B6xC3H F1 mice. Embryos were im- 
planted into the oviduct of pseudopregnant females using standard surgical 
techniques (Hogan et al., 1986). Offspring were identified as transgenic by 
Southern hybridization of digested  DNA  isolated from tail  (Southern, 
1975). Progeny of founder mice were screened for the transgene using either 
slot blot hybridization and/or polymerase chain reaction analysis of DNA 
isolated from ear punches. Mice were housed under sterile conditions in 
microisolator cages and siblings of founders and facility sentinel animals 
were routinely screened for the presence of mouse hepatitis virus, pneumo- 
nia virus, sendal virus, and rheo virus. All tested negative. 
Gene Transfection 
HepG2 hepatoma cells were cultured on glass chamber slides (Nunc) in a 
3:1 mixture of DME:F12 media supplemented with 10% bovine calf serum 
(Hyclone  Labs., Logan,  LIT). TTR-K14.P  plasmid DNA was transfected 
into cells overnight  using calcium phosphate precipitation (Graham and Van 
der Eb, 1973). The precipitate was removed and cells ware washed twice 
with PBS after which culture media was added.  At 48 h posttransfection 
cells were fixed and processed for immunolabeling. 
Immunofluorescent Labeling Analysis 
Cultured Cells.  Transfected  HepG2  cells were  double immunolabeled 
using 1:300 dilution of a rabbit  polyclonal antibody against  the neuropeptide 
substance P (Wako Bioproducts, Richmond, VA) to detect the KI4.P protein 
and a rat monoclonal antibody (Troma 2, undiluted) against K8 (Boiler and 
Kemler,  1983) to detect the endogenous  network.  Primary antibody label- 
ing was visualized using fluorescein-conjugated  goat anti-rabbit IgG (Cap- 
pel,  Malvern, PA) and Texas red-conjugated goat anti-rat IgG (mouse 
absorbed; Sera Labs., Crawiey  Down,  Sussex,  England) secondary anti- 
bodies. Labeled cells were detected  using a Zeiss Axioscop microscope 
equipped  with fluorescent  optics. 
Liver Tissue.  Immunofluorescence  analysis was performed on liver tis- 
sue that was frozen on dry ice and stored at -80°C until sectioned.  Tissue 
sections 6-10-#m thick were cut using a cryostat, mounted on Glass Plus 
slides,  and stored at -80°C.  Slides  were air dried for 15 rain, fixed in 
-20°C acetone for 10 rain, air dried, and placed in PBS. Immunolabeling 
to detect keratin filaments  used antibodies to substance P,  troma 2,  or 
a  monospecific  rabbit antibody  made  to  K18  protein  (Stellmach and 
Fuchs,  1989).  Desmosome complexes  were labeled using a  rabbit anti- 
desmoplakin I/If antibody (Pasdar and Nelson, 1988).  Sections  were in- 
cubated in primary antibodies 1-2 h at room temperature,  washed three 
times in PBS (10 rain each), and incubated with an appropriate secondary 
antibody fluorophore  conjugate.  Secondary antibodies were applied for 25 
min at room temperature followed by washing with PBS. Double-label im- 
munofluorescence  analysis was performed by sequential incubation of sec- 
tions  with primary antibodies followed  by appropriate  secondary anti- 
bodies. 
Light and Electron Microscopic  Analysis 
Mice were anesthetized by injection of avertin anesthesia (i.p.), killed by 
cervical dislocation, and liver tissues removed. For light level analysis, tis- 
sue was placed in either 4 % paraformaldehyde  or Histocboice fixative (Am- 
resco Inc., Solon, OH). Tissue was fixed overnight, dehydrated through al- 
cohols,  embedded in paraffin wax, sectioned  (8-10/~m), and stained with 
hematoxylin and eosin. To examine glycogen content fixed liver sections 
were stained using the periodic acid-Schiff procedure.  To detect lipid con- 
tent fresh frozen liver sections were fixed for 10 rain at room temperature 
in 4% paraformaldebyde  in PBS, washed, and stained in freshly filtered oil- 
red O in 70% isopropanol  for 10 min. For electron microscopy, tissue was 
immersion fixed for 2 h at room temperature in 3 % glutaraldehyde  made 
in 0A M Sorensen's phosphate buffer (pH 7.3), processed for epon embed- 
ding and examined on a JEOL 100 electron microscope. 
Northern Analysis of Transgene Expression 
Total RNA was extracted from heart, brain, kidney, and liver tissues using 
Trizol solution (BRL). Tissues ware disaggrngated in Trizol using a polytron 
and RNA extracted  and precipitated according to the manufacturers pro- 
tocoL  20/~g of total RNA was electrophoresod  through a  1.29[ agarose 
formaldehyde  denaturing gel, transferred overnight in 10x  SSC  (1.5 M 
NaC1, 0.15 M  sodium citrate, pH 7) to Nytran membrane, baked 2 h at 
80°C,  and then hybridized at 68°C to a [32p]CTP-labeled ribopmbe made 
to the full-length sequence of the K14.P cDNA. 
Keratin Protein Isolation and Immunoblot Analysis 
Keratin proteins were isolated from liver essentially using the procedure of 
Achtstaetter et al. (1986). Briefly, up to 1 g of tissue was homogenized in 
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Na2PO4.2H20,  1.5 mM KC1, 10 mM EDTA, 0.1 mM DTT, pH 6.8) using 
a polytron. Three volumes of very high salt buffer (2 M KCI, 200 mM NaCI, 
10 mM Tris-HCl, pH 7.4,  1 mM /~ME, 0.5%  Triton X-100, 0.3  mg/rnl 
PMSF) were added, the suspension was stirred for 30 rain at 4°C,  and 
insoluble material pelleted by centrifugafion at 10,000 g for 20 rain. Two 
additional washes  in high salt buffer were performed and the pellet was 
resuspended in 6 M urea, 50 mM Tris, pH 7.4, and 10 mM OME. Protein 
concentration was measured using a Bradford protein assay (Biorad Labs., 
Hercules, CA). 
Immunobiot analysis was performed on protein samples separated on a 
10% polyacrylamide gel.  Proteins were electrophoretically  transferred to 
a nitrocellulose  membrane and processed for immunolabeling (Towbin et 
al., 1979). The membrane was exposed to the substance P antibody (1:300), 
washed, and incubated with an alkaline phosphatase-conjngated goat anti- 
rabbit secondary antibody. Antibody binding was detected by incubation with 
5-bromo-4-chloro-3-indolyl-phosphate  (BCIP) substrate and color develop- 
ment reagent according to the manufacturer's instruction 0Biorad Labs.). 
Bile Flow Measures in Isolated Perfused Liver 
Mice were anesthetized with 1 g/kg urethane i.p. and the liver perfused via 
the portal vein as described in Liu et al. (1992) with Krebs-Henseleit buffer 
(118.5 mM NaCI, 24.9 mM NaHCO3,  1.2 mM KH2PO4, 1.19 rnM MgSO4, 
4.74 mM KCI, and 1.27 CaC12, pH 7.4) at a flow rate of 4 ml/min/g liver 
in a single pass perfusion system. The bile duct was cannalated with PE-10 
tubing. Perfusate was oxygenated with 95%O2/5%CO2  and the liver main- 
tained at 36°C. Bile was collected every 10 rain throughout the experiment 
(70 rain) and the volume determined gravimetrically assuming a density of 
1.0. [3H]Taurocholate (TC; 8 nCi/t~mol) was infused into the cannula lead- 
ing to the portal vein at increasing concentrations for 10 rain each. Inflow 
concentrations of TC were 56 :i: 1.7, 108 +  1.6, and 237  +  13 nmol/ml. 
Aliquots of  bile (10 ~l) and perfusate (inflow and outflow; 200/~l each) were 
mixed with 5 ml Aquasol (New England Nuclear, Boston, MA) and assayed 
for radioactivity  in a 1500 series Tricarb Liquid Scintillation  Analyzer. The 
bile acid secretory rate (BASR) was calculated based on the formula BASR 
-- BF × C, where BF is bile flow and C is bile acid concentration in the bile. 
Results 
Isolation of TTR-KI4.P Transgenic Mice 
To target expression of  the K14.P keratin to liver hepatocytes 
the eDNA  was placed  downstream  of a 400-bp  sequence 
containing proximal promoter and enhancer elements of the 
mouse transthyretin (TTR) gene (Fig. 1 a). These regulatory 
sequences have been shown to be transcriptionally active in 
liver and have been used to direct transcription  of a trans- 
thyretin minigene (Yan et al., 1990) and the creatine kinase 
gene (Koretsky et al.,  1990) in transgenic mice. 
To  detect  cellular  expression  of the  transgene,  a  K14 
eDNA fragment containing the carboxy tail of  the neuropep- 
tide substance P (SP) added at the 3' end was used (Albers 
and Fuchs,  1987). The P tag provided a specific immuno- 
logic epitope that allowed detection of transgene expression 
in liver hepatocytes.  Recent studies in rat have found that 
K14 keratin  is made by non-parenchymal  liver  epithelial 
cells (LECs) located inthe biliary epithelium and Glisson's 
capsule (Blouin et al., 1992; Marceau et al., 1992). Thus the 
SP epitope provided a means to discriminate between cells 
expressing mouse KI4 and cells expressing the K14.P trans- 
gene product. 
Before injection of the TTR-K14.P DNA into mouse em- 
bryos, we tested whether the K14.P protein would assemble 
properly with the endogenous hepatocyte filament network 
by transfecting the pG3TTR-FA4.P plasmid into the human 
hepatoma cell line HepG2 (Fig.  1 b).  At 48 h, transfected 
cells were fixed and double labeled with the rabbit substance 
P antibody to detect the K14.P protein,  and the rat anti-K8 
antibody to detect the endogenous network (Fig. 1 b). Anti- 
SP labeling colocalized with the anti-K8-1abeled endoge- 
nous network with no detectable perturbation in filament or- 
ganization. 
TTR-K14.P Transgene Expression in Liver Hepatocytes 
Seven TTR-K14.P founder mice were bred to produce prog- 
eny for use in biochemical and histological analysis. No ex- 
ternal physical differences were observed in the transgenlc 
lines and thus far, all appear to have a normal lifespan. Copy 
number  was  estimated  by  densitomeudc  measure  of au- 
toradiograms from slot blots on which the isolated transgene 
EcoR1 insert was loaded as a standard and ranged from one 
(line 454-1) to twelve copies  (highest;  397-7). Five  lines 
(39%7, 482-2,484-4, 454-1, 454-2) were obtained that bad 
detectable levels of transgene expression by Northern (not 
shown) and Western (Fig. 1 c) hybridization analysis. To de- 
tect transgene  expression,  intermediate  filament  proteins 
were purified  from liver  tissue using high salt extraction 
(Achtstaetter et al., 1986). The transgene product was not 
visible on Coomassie stained gels, though it was detectable 
using Western analysis (Fig. 1 c). The K14.P protein was de- 
tected using the substance P antibody followed  by an alkaline 
phosphatase-conjugated  anti-rabbit antibody. Binding was 
visualized by the appearance of alkaline phosphatase  cata- 
lyzed substrate reaction product at the predicted size ('~50 
kD) of the K14.P protein.  A fainter band was also detected 
above FA4.P and may represent a product made using an up- 
stream ATG added during plasmid construction that would 
add an additional 28 amino acids to the amino terminus. If 
this is the case, addition of these residues could affect fila- 
ment assembly, though no indication of  this was given by the 
morphology of the filament networks of hepatocytes trans- 
fected with the pG3TTRK14.P plasmid (Fig.  1 b). 
The 397-7 and 482-4 line had the highest level of expres- 
sion and were bred to produce  mice homozygous for the 
transgene  as judged by band intensities  on slot  blot and 
Southern hybridizations. Though these lines did exhibit the 
best level of  expression, it was still quite low when compared 
to endogenous keratin levels; transgene expression was esti- 
mated to be less than 1% of  the total extractable keratin pro- 
tein  by  comparing  band  intensities  densitometrically  to 
known amounts of standard  K14.P proteins  purified from 
overexpressing bacteria (data not shown). The reason for this 
relatively low level of expression is not known. 
The endogenous transthyretin  gene is also normally ex- 
pressed in  the  choroid plexus epithelium of  the  brain.  It  was 
of  interest  therefore  to examine the tissue  specificity  of  the 
TTR promoter and enhancer elements used in making the 
TTRK14.P transgenics.  Total  RNA  was isolated  from heart, 
brain, kidney, and liver  tissues  of a control and a 397-7 
homozygous  mouse  and examined  by Northern  analysis 
using a riboprobc made to the full-length  KI4.P cDNA  se- 
quence (Fig. I d). For this line  and the 482-4 line (not 
shown), transgene expression  was only detected  in  the  liver. 
Incorporation of  K14. P Causes Alteration 
of the Hepatocyte  Keratin Network 
To determine whether the K14.P keratin incorporated  into 
the in vivo  hepatocyte  network,  indirect  immunofluores- 
cence was used to label IF networks in transgenlc and control 
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Figure 1. Genetic map and expression of the TTR-KI4.P transgene.  (a) The K14.P cDNA was targeted to mouse liver hepetocytes using 
elements  of the transthyretin  (TrR) gene promoter and enhancer.  The P tag sequence encodes an antigenic portion of the neuropeptide 
substance P and serves as a specific marker of the transgene (Albers and Puchs, 1987). The 3' sequences are from the human growth hor- 
mone gene (hGH; sequence from +2 to the poly A signal) which provide an intron/exon  splicing segment that serves to upregulate expres- 
sion and a polyadenylation signal.  (b) To test expression  of the plasmid and incorporation of the transgene  protein into the endogenous 
network, pG3TTR-K14.P was transfected  into HepG2 hepatoma cells.  K14.P expression  was visualized  using double-label immunocyto- 
chemistry.  Left panel shows cells labeled with the anti-SP antibody and an FITC-conjugated goat anti-rabbit secondary.  Right panel is 
the same field labeled  with the troma 2 rat monoclonal and a Texas red-conjugated goat anti-mouse secondary.  Labeling was visualized 
using a Zeiss Axioskop microscope equipped with fluorscent  optics.  (c) Western blot to detect K14.P protein in transgenic  livers using 
the substance P antibody. (Lane 1 ) K14.P marker protein (",50 kD) isolated from cells transfected  with K14.P; (lane 2) no sample loaded; 
(lane 3) nontransgenic  control, 20/tg, (lane 4) 397-7F1 transgenic,  20/~g; (lane 5) 397-7F2 transgenic,  20 ktg; (lane 6) 397-7F2 transgenic, 
20 ~tg; (lane 7) 397-7F2 transgenic,  20/~g; (lane 8) 482-2F1 tranagenic,  30 ~g; (lane 9) 482-4F1  transgenic,  30 ttg; (lane  10) 454-1F1 
transgenic,  30 I~g; (lane//) 454-2F1 transgenic,  30/zg. Samples in lanes 5 and 6 were from homozygotes. (d) Northern blot shows tissue 
specificity of  the TTR promoter and enhancer sequences. 20/~g of  total RNA from tissues of one control and one homozygous  397-7 mouse 
was loaded per lane,  transferred  to Nytran membrane, and probed with a 32p-labeled probe to the full-length  K14.P sequence.  Control 
heart, brain, kidney, and liver as well as transgenic heart, brain, and kidney had no detectable transgene mRNA expression whereas hybrid- 
ization to a band at the predicted size of the transgene (arrow) was detected  in the transgenic  (line 397-7) liver. Ribosomal RNA markers 
are shown on the left.  Bar: (b) 6 ~m. 
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anti-KS or K18 antibody and/or the substance P antibody. In 
control hepatocytes, anti-K18 labeling  showed an extended 
keratin network distributed throughout the cytoplasm (Fig. 
2 a). An increase of labeling intensity  was typically found 
around bile canaliculi,  a tubular space formed between adja- 
cent hepatocytes that delineates the beginning of  the bile duct 
system.  Substance P antibody labeling  was not detected in 
hepatocytes of  control liver (Fig. 2 b). To examine the IF net- 
work of transgenic  hepatocytes, double label immunofluo- 
rescence using the anti-K8 (rat monoclonal) and substance 
P (rabbit polyclonal) antibodies was carried out (Fig.  2, c 
and d).  Double-labeled hepatocytes were abundant,  with 
most hepatocytes showing some degree of network permr- 
hation  (Fig.  2,  c-f).  The degree  of perturbation  ranged 
in severity:  some hepatocytes had filaments  that appeared 
slightly fragmented (Fig. 2 c and d) whereas others had fila- 
ments that were totally collapsed in large aggregate  struc- 
tures found adjacent to the plasma membrane (Fig. 2, e and 
f). No apparent regionalization  of transgene  expression in 
the liver was observed. 
While nearly all hepatocytes were double labeled for the 
K14.P and K8 proteins,  some anti-KS-labeled cells (arrows, 
Fig. 2, c and d) did not express the K14.P protein, even in 
mice bred to homozygosity. This lack of labeling may repre- 
sent hepatocytes that do not express transthyretin  or may be 
other cell types (e.g., Kupffer cells, fat storing cells, and en- 
dothelial  cells) that normally do not express transthyretin. 
Keratin  networks in these non-Kl4.P expressing  cells rou- 
finely appeared normal. 
Histopathology of the KI4.P  Transgenic Liver 
The histology of transgenic  and control livers was examined 
using light level microscopy to determine whether K14.P ex- 
pression induced abnormal changes. In general, no major al- 
terations were detected in young mice (up to ,,04 months old) 
when compared to controls.  However, in many older trans- 
genic mice (•75  % in the 397-7 line), various degrees of his- 
topathologic  change  had  occurred that  were not present 
in age-matched  controls  (Fig.  3 a).  In some transgenics, 
marked degenerative  changes  characterized by ballooning 
and clear cell changes  of the cytoplasm were a prominent 
feature and were associated with nuclear degeneration in 
some areas (Fig.  3 b). Changes  in some samples appeared 
regionalized,  being more severe in hepatocytes surrounding 
the central vein, whereas in others the entire  lobe was in- 
volved.  Numerous areas of inflammatory  infiltration  0ym- 
phohistiocytic  nodules) (Fig.  3,  c and d) as well as focal 
punch-out necrosis were noted (Fig.  3 e).  In some cases 
transgenic  liver exhibited  loss of adhesion at cell borders 
(Fig. 3  f). Three cases, of approximately  sixty examined, ex- 
hibited neoplastic nodule formation (bepatocellular hyper- 
plasia;  Maronpot et al., 1986) in areas of marked cytoplas- 
mic degenerative changes, especially where clear cell changes 
had occurred (Fig. 3 g). Focal necrosis and accumulation  of 
small ductular-like  cells that appeared to be oval cells were 
also recognized (Fig. 3 h). Oval cells are considered imma- 
ture cells that undergo proliferation  in livers of rodents  ex- 
posed to carcinogens and may serve as liver stem cells (for 
review see Sell, 1990). Mallory body structures were not ap- 
parent in any of the liver tissues examined. 
Liver plays an important role in glycogen metabolism and 
contains enzymes for its synthesis and storage.  As needed, 
glycogen is broken down into free glucose and released into 
the blood. Glycogen content in transgenic  mouse liver was 
evaluated by PAS staining and found to have accumulated  at 
markedly increased  levels (Fig. 4 a) when compared with 
age-matched control liver (Fig. 4 b). Glycogen was typically 
present in large clumps throughout the cytoplasm suggesting 
a defect in processing and/or secretion was present in the he- 
patocytes of transgenics.  Lipid accumulation  was also exam- 
ined by staining  frozen sections of control and transgenic 
livers with oil-red O (Fig. 4, c and d). Control livers typi- 
cally showed tittle to no staining, where the majority of sec- 
tions  examined  from older transgenics  had a  marked in- 
crease. Lipid accumulation  by itself is considered a benign 
change, though it may represent a precursor to changes lead- 
ing to conditions  such as cirrhosis. 
In some instances  the histopathology observed in livers ~ 
from older transgenics  was indicated  by visible white nod- 
ules on the surface of the liver. No other alterations  on the 
gross level were consistently apparent.  Liver to body weight 
ratios for transgenic and control livers showed no significant 
difference between the two groups (not shown). 
Electron Microscopy  Analysis of  the TTR-Kl4.P Liver 
Electron microscopic examination of the transgenic liver tis- 
sue showed alterations  in ultrastructure from control liver 
(Fig. 5 a). As expected from the light level microscopic anal- 
ysis, transgenic liver hepatocytes had extensive glycogen ac- 
cumulation  (Fig. 5 b). An increased number of fat vacuoles 
of various sizes was also apparent throughout the liver (Fig. 
5 c). In some hepatocytes, clumps of dense, amorphous ma- 
terial  near the plasma membrane were identified  (arrows, 
Fig. 5 d). This material  appears similar to aggregated kera- 
tin protein,  though  unequivocable identification  cannot be 
made without further immunological  analysis. 
Light level  histological  analysis  of transgenic  liver re- 
vealed areas in which hepatocytes were less cohesive (Fig. 
3 f). It was of interest therefore to examine desmosome con- 
tacts since this type of junctional complex has close spatial 
and functional connections with keratin filaments. Light level 
analysis of desmosome-keratin associations using  double- 
label immnnofluorescence  was carried out on frozen fiver 
sections labeled with the anti-KS rat antibody and a rabbit 
polyclonal antibody directed against  the desmoplakin  I/H 
proteins (Pasdar and Nelson,  1988).  Despite disruption of 
the keratin network and in some cases total loss of filaments 
from the cytoplasm, no significant redistribution  in the DP 
I/II antigens was apparent in the transgenic hepatocytes (not 
shown). However, preliminary examination of two transgenic 
liver samples by electron microscopy did show abnormal 
desmosomal linkages between cells (Fig. 5 e). Desmosomes 
appeared  separated  from the adjacent cell at the plasma 
membrane, which would result in loss of cell adhesion. 
Alteration of the Keratin Network Inhibits Bile Flow 
and Bile Acid Secretion 
A major function  of liver hepatocytes is to secrete bile, a 
digestive  emulsifying  solution  composed  of  bile  acids, 
lipids, proteins,  anions,  and cations (Nathanson  and Boyer, 
1991). Bile is formed by the transport of osmotically active 
Albers et al. Keratin Expression in Liver of Transgenic Mice  161 Figure 2.  Transgene product expression in liver hepatocytes. Frozen sections of liver from control (a and b) and transgenic mice (c-f) 
were immunolabeled to detect keratin expression. Control liver was double labeled with the monospecific anti-K18 antibody (a) and the 
substance P antibody (b). Anti-K18 labeled  the endogenous network and showed filaments extendin~ throughout the hepatocyte with associ- 
ations at the nuclear and cytoplasmic  membranes. Arrowhead points to bile cannaliculus. No reactivity was detected with the anti-SP anti- 
body (b). Section from transgenic liver (c and d) double labeled  with the troma 2 antibody (c) and the anti-SP antibody (d) to show overlap- 
ping expression of the KI4.P keratin and the endogenous network. Note that filaments appear fragmented and shorter than in control tissue. 
Some cells (arrows) did not express the TTR-K14.P product. Axrowhead points to bile cannaliculus, e andfshow areas in the transgenic 
liver labeled with anti-SP where the filament network is more severely disrupted. Note intense labeling at plasma membrane and lack 
of filaments in cytoplasm. Sections were labeled  with the anti-SP antibody followed  by incubation with an FITC-conjugated  IgG. Bar, 30 #m. 
The Journal of Cell Biology,  Volume 128, 1995  162 Figure 3. Histopathology of K14.P transgene expressing liver. To examine whether KI4.P expression altered the histology of transgenic 
liver, tissue sections were fixed, processed, and stained with hematoxylin and eosin. (a) Control liver; (b) transgenic liver showing fatty 
and clear cell changes; (c) lower magnification illustrating islands of inflammatory cell infiltration  (arrows); (d) a more advanced inflamma- 
tory infiltrate surrounding a vein; (e) area of focal necrosis demarcated by arrowheads. Note darker staining cells with pyknotic nuclei 
and inflammatory infiltrate; (f) field showing loss of  cellular  adhesion (arrowheads) primarily  seen in central vein areas of some specimens; 
(g) transition zone marked by arrows between an area with clear cell changes to one containing a neoplastic nodule (hepatocellular  hyperpla- 
sia); (h) higher magnification of a portal triad region that exhibited marked inflammatory infiltration and contained numerous oval cells. 
Arrows point to one area of oval cells; arrowhead, hepatocyte, cv, central vein. Bars: (b)  100/Lm;  (g) 100 ~m; (h) 50 pm. Figure 4. Transgenic livers accumulate glycogen and lipid. Overall glycogen accumulation was markedly increased in transgenic livers 
as shown using PAS staining, a shows control liver which typically had small amounts of glycogen staining in hepatocytes surrounding 
the central vein; b is liver tissue from transgenic showing marked increase in glycogen in nearly all hepatocytes in this field. Lipid was 
detected using oil-red O staining and was elevated in some, though not all, transgenic samples (d) when compared to controls (c). cv, 
central vein; by, blood vessel. Bar, 100 ~tm. 
bile acids such as taurocholate across the basolateral (sinu- 
soidal)  domain  of  the  plasma  membrane  to  the  apical 
(canalicular) domain. Flow into the bile canaliculus is fol- 
lowed by the passive diffusion of  water until osmotic equilib- 
rium is reached. To assess whether alteration of the keratin 
network affected bile secretory function, bile flow and bile 
acid secretion were measured in control and 397-7 and 482  -4 
transgenic mice. Tritium-labeled taurocholate (TC), a major 
component of bile, was used to measure the efficiency of a 
perfused liver to extract TC from the perfusate and secrete 
it into bile (Liu et al.,  1992).  Measures  of taurocholate 
secretion from four 397-7 transgenic and five control livers 
showed the transgenics to have a 1.5-2-fold reduction in bile 
flow (#l/rain/g) (Fig. 6, top).  The maximal bile acid secre- 
tory rate (SI~)  was  also  significantly decreased in trans- 
genic mice relative to controls (Fig. 6, bottom).  The concen- 
tration of TC in secreted bile was unchanged in transgenics 
as compared to controls (Fig. 6, middle). Bile flow measures 
were also carried out on three 482-4 transgenics and age 
matched controls (not shown), and, as in the 397-7 line, had 
a  1.5-2-fold reduction in flow (transgenic,,g  =  1.79;  con- 
trolav~ =  3.08)  and a decrease in the SI~ (transgenic,vs  = 
191; controL,  s  =  369). 
Discussion 
We have shown using a transgenic mouse model system that 
the ectopic expression of  an epidermal keratin in hepatocytes 
causes perturbation of the endogenous KS/K18 intermediate 
filament network, and can lead to histopathologic and func- 
tional abnormalities  of the liver.  These abnormalities  in- 
cluded cytoplasmic degeneration in hepatocytes, infiltration 
The Journal of Cell Biology,  Volume 128, 1995  164 Figure 5. Electron microscopy analysis of transgenic liver. The ultrastructure of the transgenic  rivers was examined by electron microscopy 
and showed alteration  in structure from control liver shown in a. b illustrates  the increased amounts of glycogen (8) accumulated in the 
cytoplasm of hepatocytes, c shows a portion of a hepatocyte with numerous fat-containing  vacuoles.  This field shows medium-sized vacu- 
oles,  though small and large vacuoles were also apparent.  Arrows in d  point to dense material  that may be aggregated keratin protein, 
similar to that detected on the light histology level by immunolabeling with anti-substance  P antibody (see Fig. 2 e). e shows an abnormally 
wide junction between two hepatocytes. Arrowheads point to desmosome structures  that appeared separated,  n, nucleus; bc, bile canalicu- 
lus; g, glycogen; v, vacuole.  Magnifications  are: (a) 6,000; (b, c, d) 5,500; (e) 29,000. Bars: (a) 4.7/zm; (b, c, and d) 2.5 #m; (e) 0.45 t~m. 
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Figure 6. Bile  flow  measures in transgenic and control mouse liver. 
To evaluate secretory function in the TTRK14.P liver, bile flow 
(top), bile acid concentration (middle),  and bile acid secretory rate 
(bottom) in four 397-7 transgenic and five age and sex matched con- 
trol livers were measured. Each point is the mean + standard error. 
*p <  0.05; **p, 0.01, significantly different from control group. 
Similar results were obtained using mice in the 482-4 line. 
of inflammatory cells,  fatty  accumulation,  glycogen ac- 
cumulation, hepatocellular hyperplasia, and decreased bile 
acid flow. Although the underlying cellular mechanism of 
these disturbances is not as yet understood, an increase in 
the severity of the histopathology occurred with age, indicat- 
ing that progressive damage to the hepatocyte ultimately led 
to the degeneration in liver function. The observed histo- 
pathologic findings are not specific for, but may be seen with, 
repeated toxic injury to the liver. Therefore, this transgenic 
animal model may provide a useful tool for studying patho- 
genesis as well as the tumorigenic effect of toxin induced 
liver disease. 
Livers of the transgenic mice displayed cellular and func- 
tional abnormalities even though transfection of the TTR- 
K14.P plasmid into cultured hepatocytes caused no obvious 
alteration in the keratin network. Thus, the composition of 
the network appears to be more crucial in the context of the 
tissue than in transfected cells grown in plastic, i.e., hepato- 
cytes in vivo may require a keratin network finely tuned to 
the metabolic and secretory functions of the liver, challenges 
not presented to cells in culture. This contention is in agree- 
ment with the findings of  Blessing and colleagues (1993) who 
showed that ectopic expression of either the type II K1 epi- 
dermal keratin alone or in combination with its type I K10 
partner caused an insulin-dependent form of diabetes melli- 
tus characterized by reduction in/~ islet cells and a massive 
reduction of insulin. Pancreatic islet cells that overexpressed 
either K1 alone (but not K10) or in conjunction with K10 
keratin had accumulated fibrous material and a reduction in 
the number of insulin-secretory vesicles. What was surpris- 
ing in these studies was that the K10 keratin when expressed 
alone, even in large excess, did not affect islet cell secretion. 
The basis for this apparent keratin specificity to perturbation 
of islet cell function is not known. Even so, these results and 
our findings in the TTR-K14.P transgenics suggest that the 
keratin filament network may play a role in secretion. 
To assay liver function in the TTR-K14.P transgenics, bile 
acid production was measured. Bile secretion represents an 
important route for the elimination of both endogenous and 
exogenous  organic  compounds  such  as  cholesterol,  bile 
salts, drugs, and their metabolites, which cannot be easily 
removed by the kidney from the body (Nathanson and Boyer, 
1991). Hepatocytes behave as polarized epithelial cells and 
transport bile secretory products from the sinusoidal to the 
canalicular domain. The cytoskeletal components of the he- 
patocyte are thought to have an important role in bile acid 
uptake, transport, and secretion. Microtubules form a dense 
network near the  sinusoidal membrane and from studies 
using microtubule disruptors, appear to function in vesicular 
internalization and transport through the cytoplasm (Goltz 
et al., 1992; Feldman, 1989). Microfilaments are densely ar- 
ranged at the canalicular membrane and may mediate coor- 
dinated contractions between hepatocytes to facilitate bile 
flow (Oshio and Phillips, 1981; Smith et al., 1985). Keratin 
intermediate filaments also have a close association with the 
canalicular membrane, though their role in bile acid uptake, 
transport, and secretion has been difficult to evaluate.  Dis- 
ruption  of keratin  filaments in  cultured hepatocytes was 
achieved by exposure to  nickel chloride and caused de- 
creased uptake of applied horseradish peroxidase, an inabil- 
ity to secrete the organic anion fluorescein diacetate, and dis- 
persion  of bile  canalicular  structures  (Kawahara  et  al., 
1990). These alterations in secretion may have resulted from 
a direct perturbation of the keratin network, though another 
possibility  is  that  the  phenotype was  induced  by  a  less 
specific, nickel-based toxicity. 
The  cellular  location  at  which  bile  acid  secretion  is 
impeded in the transgenics is unknown; it may occur during 
uptake, transcytosis, secretion, or may be slowed in all three 
domains. Because transport of taurocholate across the sinu- 
soidal domain normally exceeds that across the canalicular 
domain by sixfold (Nathanson and Boyer,  1991),  it seems 
more likely that the defect occurs at the canalicular mem- 
brane, the rate-limiting step. Another possibility is that bile 
flow in transgenic hepatocytes is physically impeded due to 
the increased number of fat vacuoles and glycogen deposits. 
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intermediate age at which some degree of histopathologic al- 
teration could be present.  Further studies measuring flow 
rates  in young transgenics,  typically without overt histo- 
pathology, and older mice should clarify this issue. 
A common feature observed in degenerative diseases of 
the liver is the formation of Mallory bodies. Mallory body 
structures are amorphous in nature and contain bundles of 
intermediate filaments organized in various arrays (Franke et 
al., 1979; Denk et al., 1982; French et al., 1987; Yokoo et 
al., 1972). They can be induced in mouse liver by prolonged 
feeding of griseofulvin and are typically arranged in promi- 
nent perinuclear arrays (Denk et al., 1979). Though Mallory 
bodies are associated with a number of  hepatic disorders, the 
conditions that lead to their development are not understood. 
Since expression of the K14.P keratin caused perturbation in 
the hepatocyte IF network, it was possible that Mallory bod- 
ies would develop in the transgenic livers. However, exami- 
nation of  transgenic hepatocytes on the light and electron mi- 
croscope level showed no evidence of typical Mallory body 
structures. Cells in the transgenic liver with abnormal kera- 
tin networks had filaments that were fragmented and col- 
lapsed to the plasma membrane. Thus, the collapsed keratin 
networks in the transgenic liver appear to be induced by a 
separate mechanism from that involved in the formation of 
mature Mallory bodies. It may be that other components or 
physiological conditions are required for their formation. 
Although a function for IFs as a group remains undefined 
(Oshima, 1992),  studies using transgenic mice that express 
mutated keratin proteins  in skin have demonstrated their 
crucial role in maintaining keratinocyte structure and im- 
parting  mechanical  integrity to  the  skin  (Fuchs,  1994). 
Transgenic mice that expressed truncated or site mutated 
keratin genes exhibited keratin filament clumping and resul- 
tant blistering of the skin (for review see Coulombe, 1993). 
Gene mapping and DNA sequence studies have shown that 
patients with the dominantly inherited forms of epidermoly- 
sis bullosa simplex (EBS) and epidermolytic hyperkeratosis 
(EH)  blistering  diseases  have  defective  keratin  proteins 
resulting from point mutations in epidermal keratin gene se- 
quences (Coulombe et al., 1991; Bonifas et al., 1991; Lane 
et al., 1992;  Chan et al.,  1993).  Disease severity has been 
correlated with the relative importance of the affected amino 
acid residue(s) to this filament structure, i.e., mutations in 
highly conserved residues caused a severe blistering pheno- 
type whereas those in less conserved residues led to milder 
phenotypes (Letai et al., 1993). Interestingly, EH is charac- 
terized by diminished cohesiveness between keratinocytes, 
similar to the reduced cohesiveness observed in some of the 
TTR-K14.P liver specimens. Keratinocytes with perturbed 
keratin networks also displayed abnormalities in organelle 
and-nuclear placement, suggesting the network serves as a 
cellular scaffold (Coulombe et al.,  1992).  Hepatocytes are 
likely to have a similar scaffold organization that if  perturbed 
could disrupt normal cellular organization. 
Studies of simple epithelial keratin function in genetically 
modified embryonic stem cells have shown that the K8 kera- 
tin is not required for the early phases of mouse develop- 
ment;  K8  deficient ES  cells differentiated into embryoid 
bodies composed of an outer polarized simple epithelium 
and  internal  primary  ectoderm  that  developed  normally 
(Baribault and Oshima, 1991; but see Trevor,  1990).  Thus, 
at early time in development keratin networks may be non- 
essential. In further examination of  the role of keratins, Bari- 
bault and colleagues (1993)  isolated gene knockout mice 
containing a null mutation in the mouse K8 gene (mKS-/-). 
Homozygous mutant embryos were growth retarded, and, 
though some survive to adulthood, most die between El2 
and E13, possibly from internal bleeding. During this time 
fetal hematopoiesis shifts from the yolk sac to the liver and 
it may be that the keratin filament  deficient fetal liver was un- 
able to accommodate the massive increase in hematopoiesis 
(Baribault et al.,  1993).  Interestingly, other studies by H. 
Baribault and colleagues (1994) on inKS-~- survivors show 
that some of  these mice exhibit inflammatory cell infiltration 
and slight elevation in levels of the hepatic enzymes alanine 
(AST) and asparate (ALT) aminotransferase, findings typi- 
cally associated with hepatocyte injury. This suggests that 
lack of K8 and thus the bepatocyte IF network, has conse- 
quences on liver function. 
In interpreting the transgenic phenotype, our working hy- 
pothesis has been that the observed alterations are in some 
way linked to the perturbation of the keratin filament net- 
work. However, another possibility to explain these changes 
is that they result from an accumulation of an abnormal pro- 
tein (K14.P) in hepatocytes that, over time, leads to defects 
in cellular structure and function. Though expression of the 
transgene protein is low relative to the endogenous IF pro- 
teins, sufficient amounts of the insoluble K14.P protein may 
have accumulated in the cytoplasm to cause a nonspecific 
toxicity. Another issue is whether the general low level of 
transgene expression across lines resulted from low pro- 
moter activity or perhaps  embryonic lethality induced by 
high level of transgene protein. No significant increase in the 
number of dead pups in founder litters was observed, though 
it is possible they died in utero. 
We have used transgenic mice that express an epidermal 
keratin derivative in liver hepatocytes to examine the role of 
keratin proteins  in  cellular  and tissue  function.  Though 
K14.P formed normal appearing networks in cultured liver 
cells, in the context of the tissue its presence caused network 
abnormalities and changes in liver histology and function. 
This  model  may  have  importance  in  understanding  the 
myriad of liver disorders in which keratin filament structure 
and/or composition is abnormal. 
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